ADMA Biologics ADMA Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's gross profit?
- ADMA Biologics (ADMA) reported gross profit of $80.75M in Q1 2026.
- How has ADMA Biologics's gross profit changed year-over-year?
- ADMA Biologics's gross profit increased by 32.2% year-over-year, from $61.1M to $80.75M.
- What is the long-term trend for ADMA Biologics's gross profit?
- Over 2 years (2023 to 2025), ADMA Biologics's gross profit has grown at a 81.4% compound annual growth rate (CAGR), from $88.94M to $292.77M.
- What does gross profit mean?
- Calculated as total revenue minus the cost of revenue, representing the profit a company makes after accounting for the direct costs of production. It is a fundamental measure of a company's pricing power and the efficiency of its manufacturing or service delivery processes.